Real-time index price for Nasdaq Biotechnology Index (NBI), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

Discover seven lung cancer companies advancing promising candidates through the clinic, from viral immunotherapies to ...

Baron Funds, an investment management company, released its “Baron Discovery Fund” first quarter 2025 investor letter. A copy ...

BURLINGAME, CA, UNITED STATES, May 20, 2025 /EINPresswire.com/ -- Biotechnology Market is estimated to be valued at USD 1,034.63 Bn in 2025 and is expected to reach USD 2,330.47 Bn in 2032, exhibiting ...

Indian drugmaker Zydus Lifesciences reported a higher adjusted fourth-quarter profit on Tuesday, driven by new drug launches in the U.S., its biggest market.

Chinese biotech company 3SBio's shares surged early Tuesday after its around US$6 billion licensing deal with Pfizer to develop, manufacture and commercialize a promising cancer drug. Shares were up ...

Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer ...

AI evolves beyond mere algorithms to open up new frontiers in generative AI and agentic AI, and the art of the possible is ...

Amgen AMGN and Bristol Myers Squibb BMY are among the largest global biotechnology companies with broad and diverse ...

Regeneron Pharmaceuticals said Monday it will buy genetic testing company 23andMe out of bankruptcy for $256 million, a deal ...

FBT ETF launched 19 years ago and has delivered exceptional returns compared to the broader Health Care sector. Read why FBT ...

Learn more about whether BioCryst Pharmaceuticals, Inc. or Catalyst Pharmaceuticals, Inc. is a better investment based on ...